These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16178491)

  • 1. Systematic reviews and meta-analysis of febrile neutropenia.
    Paul M; Leibovici L
    Mayo Clin Proc; 2005 Sep; 80(9):1122-5. PubMed ID: 16178491
    [No Abstract]   [Full Text] [Related]  

  • 2. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
    Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
    Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Penicillin and aminoglycoside in febrile neutropenia].
    Torfoss D; Høiby EA; Holte H; Kvaløy S
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2738-40. PubMed ID: 19079423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily aminoglycosides in patients with neutropenic fever.
    Aiken SK; Wetzstein GA
    Cancer Control; 2002; 9(5):426-31. PubMed ID: 12410181
    [No Abstract]   [Full Text] [Related]  

  • 6. Vancomycin does not benefit persistently febrile neutropenic people with cancer.
    Wade JC; Glasmacher A
    Cancer Treat Rev; 2004 Feb; 30(1):119-26. PubMed ID: 14766129
    [No Abstract]   [Full Text] [Related]  

  • 7. Is the addition of aminoglycosides to beta-lactams in cancer patients with febrile neutropenia needed?
    Contreras V; Sepúlveda S; Heredia A
    Medwave; 2016 Feb; 16 Suppl 1():e6379. PubMed ID: 26938974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems and proposals for revision of the Japanese guideline for febrile neutropenia].
    Yoshida M
    Rinsho Ketsueki; 2011 Apr; 52(4):182-9. PubMed ID: 21566403
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fever in patients with cancer].
    Watanabe K
    Rinsho Byori; 2009 May; Suppl 143():112-5. PubMed ID: 20845880
    [No Abstract]   [Full Text] [Related]  

  • 10. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.
    Furno P; Bucaneve G; Del Favero A
    Lancet Infect Dis; 2002 Apr; 2(4):231-42. PubMed ID: 11937423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low risk episodes of fever and neutropenia in pediatric oncology: Is outpatient oral antibiotic therapy the new gold standard of care?
    Ammann RA; Simon A; de Bont ES
    Pediatr Blood Cancer; 2005 Sep; 45(3):244-7. PubMed ID: 15747334
    [No Abstract]   [Full Text] [Related]  

  • 12. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C;
    Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2nd International Symposium on Febrile Neutropenia, Brussels, 14-16 December 1995.
    Hess U
    Support Care Cancer; 1996 Jul; 4(4):320-1. PubMed ID: 8829314
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
    Paul M; Soares-Weiser K; Leibovici L
    BMJ; 2003 May; 326(7399):1111. PubMed ID: 12763980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of febrile neutropenia].
    Urabe A
    Rinsho Ketsueki; 2009 Feb; 50(2):69-72. PubMed ID: 19265296
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
    Jun HX; Zhixiang S; Chun W; Reksodiputro AH; Ranuhardy D; Tamura K; Matsumoto T; Lee DG; Purushotaman SV; Lim V; Ahmed A; Hussain Y; Chua M; Ong A; Liu CY; Hsueh PR; Lin SF; Liu YC; Suwangool P; Jootar S; Picazo JJ
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S128-32; discussion S133-40. PubMed ID: 16253480
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
    Zubizarreta P; Paganini H
    Med Pediatr Oncol; 2002 Apr; 38(4):292. PubMed ID: 11920803
    [No Abstract]   [Full Text] [Related]  

  • 19. Monotherapy versus combination therapy for febrile neutropenia.
    Ramphal R
    Int J Hematol; 1998 Oct; 68 Suppl 1():S21-5. PubMed ID: 9838740
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.
    Yasuda T; Suzuki R; Ishikawa Y; Terakura S; Inamoto Y; Yanada M; Nagai H; Ozawa Y; Ozeki K; Atsuta Y; Emi N; Naoe T
    Int J Infect Dis; 2013 Jun; 17(6):e385-90. PubMed ID: 23317527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.